Evani Leite de Freitas

Evani Leite de Freitas

Auto-generated profile, based on publicly available information

Evani Leite de Freitas

Universidade Federal Fluminense. Faculdade de Farmácia. Programa de Pós-graduação em Administração e Gestão da Assistência Farmacêutica. Niterói, RJ, Brasil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2023 in Revista de Saúde Pública
Verified
Journal Article
Open access
PDF file
EFEvani Leite de Freitas
Evani Leite de Freitas
SCSabrina Calil-Elias
Sabrina Calil-Elias
RERafael Erbisti
Rafael Erbisti
BGBranca Grinberg-Weller
Branca Grinberg-Weller
EMElaine Silva Miranda
Elaine Silva Miranda
OBJECTIVE: To analyze the consumption of drugs for Alzheimer’s disease on the Brazilian private market and its geographical distribution from 2014 to 2020. METHODS: National data from the Brazilian National System of Controlled Product Management were used, regarding sales of donepezil, galantamine, rivastigmine, and memantine from January 2014 to December 2020. Sales data were used as a proxy for drug consumption and expressed as defined daily dose/1,000 inhabitants/year at national, regional, federative unit and microregion levels. RESULTS: Drug consumption went from 5,000 defined daily doses/1,000 inhabitants, in 2014, to more than 16,000/1,000 inhabitants, in 2020, and all federative units showed positive variation. The Brazilian Northeast had the highest cumulative consumption in the period but displayed microregional disparities while the North region had the lowest consumption. Donepezil and memantine were the most consumed drugs, with the highest growth in consumption from 2014 to 2020. CONCLUSION: The consumption of medicines indicated to treat Alzheimer’s disease tripled in Brazil between 2014 and 2020, which may relate to the increase in the prevalence of the disease in the country, greater access to health services, and inappropriate use. This challenges managers and healthcare providers due to population aging and the increased prevalence of chronic-degenerative diseases.

28 February 2022 in Brazilian Applied Science Review
Verified
Journal Article
Open access
PDF file
RCRanieri Carvalho Camuzi
Ranieri Carvalho Camuzi
JMJosé Rodrigo de Moraes
José Rodrigo de Moraes
RPRafaela Tavares Peixoto
Rafaela Tavares Peixoto
JCJéssica Quintanilha Marcelo de Carvalho
Jéssica Quintanilha Marcelo de Carvalho
EFEvani Leite de Freitas
Evani Leite de Freitas
SCSelma Rodrigues de Castilho
Selma Rodrigues de Castilho
Objective: to analyze adherence data by self-report, and factors related to adherence of patients monitored by a multidisciplinary team in a specialized and referral center in cardiology in the public health network. Method: descriptive cross-sectional study of the records considered at moments 0 and 4 months. Result: initially included 57 patients ≥18 years old, diagnosed with heart failure with reduced ejection fraction, mean age 55 years, 66.7% male, 75.4% NYHA functional class I / II, most polymedicated and treating 2 or more comorbidities. At 0 and 4 months, good adherence was reported by 22.8% and 29.3% of patients, respectively; the most frequent attitude of non-adherence was forgetting to take and neglecting the time to use the medications, respectively. Several associated factors have a statistically significant relationship with adherence. Conclusion: there was only 1 patient with adherence out of 4. When intervening with a pharmacotherapeutic follow-up strategy, after 4 months, an improvement in the adherence score of 1 patient out of 4 was observed, indicating that the pharmacist's role could cause a change in adherence behavior.

14 November 2021 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
RCRanieri Carvalho Camuzi
Ranieri Carvalho Camuzi
JCJéssica Quintanilha Marcelo de Carvalho
Jéssica Quintanilha Marcelo de Carvalho
RPRafaela Tavares Peixoto
Rafaela Tavares Peixoto
EFEvani Leite de Freitas
Evani Leite de Freitas
EMEvandro Tinoco Mesquita
Evandro Tinoco Mesquita
SCSelma Rodrigues de Castilho
Selma Rodrigues de Castilho
Objetivo: desenvolver um instrumento de consulta rápida e fácil para uniformizar a conduta de diferentes membros da equipe de atendimento para orientação farmacêutica e promoção da adesão à farmacoterapia na insuficiência cardíaca (IC). Método: estudo de desenvolvimento experimental que consistiu em reunir a experiência dos autores e recomendações divulgadas em publicações técnicas e científicas para elaboração de um instrumento para subsidiar a abordagem de orientação farmacêutica e promoção da adesão de pacientes com IC. Desenvolvimento: o Guia foi organizado na forma de um quadro que relaciona o tipo de abordagem de acordo com as respostas dos pacientes aos itens do Teste Morisky-Green (TMG), considerando os fatores intencionais e não intencionais que interferem no comportamento de adesão, conciliando a abordagem dos 4 itens do TMG à abordagem das 16 razões para não adesão de Culig. Acrescentou-se ainda um terceiro conjunto de fatores que são aqueles relacionados aos medicamentos. Conclusão: o Guia foi desenvolvido e aplicado, demonstrando-se uma ferramenta útil para agilizar e uniformizar as condutas durante o acompanhamento farmacoterapêutico a pacientes com IC, colaborando para melhores resultados nas intervenções para promoção da adesão.